MEDCATH INC
8-K, 1997-02-03
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: POLARIS INDUSTRIES INC/MN, S-8, 1997-02-03
Next: KITTY HAWK INC, SC 13G, 1997-02-03




                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D. C. 20549





                                    FORM 8-K

                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) January 27, 1997




                              MEDCATH INCORPORATED
                            (Exact name of registrant
                          as specified in its charter)

       North Carolina                  0-25176                 56-1635096

(State or other jurisdiction         (Commission              (IRS Employer
      of incorporation)             File Number)           Identification No.)




         7621 Little Avenue, Suite 106, Charlotte, North Carolina 28226
                    (Address of principal executive offices)

        Registrant's telephone number, including area code (704) 541-3228





                                                                     Page 1 of 6

<PAGE>

Item 5. Other Events

On January 27, 1997 MedCath  Incorporated  announced  financial  results for the
first quarter ended December 31, 1996.  Highlights included first quarter EPS of
$0.15,  record  net  revenue  and net income and  profitable  operations  at the
McAllen  Heart  Hospital.  During the first  quarter the Company also opened the
Gastonia lab, in North Carolina, and commenced management of Heart Clinic, P.A.,
in Texas. In addition,  the Company  announced its sixth Heart Hospital project,
Arizona Heart Hospital, in Phoenix, Arizona in January 1997.


Exhibits:

            99.1 - Press Release dated January 27, 1997
































                                                                     Page 2 of 6

<PAGE>
                                    SIGNATURE


         Pursuant to the  requirements  of the  Securities  and  Exchange Act of
1934,  the  Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

                              MEDCATH INCORPORATED



Date:  February 3, 1997              By:       /s/ Richard J. Post
                                              ---------------------------------
                                                   Richard J. Post
                                                   Chief Financial Officer,    
                                                   Secretary and Treasurer































                                                                     Page 3 of 6


Exhibit 99.1

              MEDCATH INCORPORATED ANNOUNCES FIRST QUARTER RESULTS


First Quarter Highlights:

   * First quarter EPS of $0.15 with record net revenue and net income
   * McAllen  Heart  Hospital   continues   improvement  and  operates
      profitably for the quarter 
   * Arizona Heart Hospital announced, five heart hospitals under development 
   * Diagnostics Division expands to 31  facilities with opening of Gastonia lab
   * Practice  Management Division commences management of Heart Clinic

Charlotte,   North   Carolina   (January  27,  1997)  --  MedCath   Incorporated
(Nasdaq/NM:MCTH)  today announced  financial results for the first quarter ended
December 31, 1996.

         Net revenue for the first  quarter ended  December 31, 1996,  increased
104% to $22.9  million  compared with $11.2 million for the same period in 1995.
Net income for the first quarter ended December 31, 1996,  increased 43% to $1.8
million  compared with $1.2 million for the same period in 1995.  Net income per
share for the first quarter ended December 31, 1996,  increased to $0.15 on 11.7
million shares  compared with $0.14 on 9.0 million shares for the same period in
1995.

         Stephen R. Puckett,  president of MedCath  said,  "While we are pleased
that the  financial  results  for the quarter  were  consistent  with  analysts'
expectations,  we are  particularly  pleased  that our  operational  progress in
fiscal 1996 has continued  into the first  quarter.  In calendar year 1996,  the
first full year of operations  for the McAllen Heart  Hospital,  we believe that
the hospital has achieved a dominant 44% cardiac cath lab market  share.  During
that period,  the hospital  treated 2,330  patients in its cardiac cath labs and
performed  354 open heart  procedures.  During the first quarter of fiscal 1997,
the average daily census at the McAllen Heart Hospital was 40, procedure volumes
continued  to  increase  and the  hospital  experienced  record net  revenue and
operated profitably."

          During the first quarter,  each of the Company's  operating  divisions
continued their expansion. The Company announced the formation of a venture with
the Arizona Heart  Institute to construct a new heart  hospital to be located in
Phoenix,  Arizona. To be named the Arizona Heart Hospital,  the venture plans to
complete  the  hospital  by Spring  1998 and will be the  Company's  sixth heart
hospital  project.  The Diagnostics  Division expanded with the opening of a new
cath lab pursuant to a joint venture  agreement with the 442-bed Gaston Memorial
Hospital in Gastonia,  North Carolina.  The opening of this lab brings the total
number of mobile  and  fixed-site  facilities  either  owned or  managed  by the
Company to 31. The Practice  Management  Division commenced  management of Heart
Clinic,  P.A. on October 1, 1996. Heart Clinic is a  seven-physician  cardiology
group  located in McAllen,  Texas,  and is the third  physician  group  practice
managed by the Company.


                                                                     Page 4 of 6

<PAGE>

         In closing, Mr. Puckett said, "We continue to be enthusiastic about the
progress we are making.  All three  divisions are  performing  very well, and we
believe this momentum will continue  throughout the year.  Clearly,  MedCath has
established itself as a unique company  specializing in very attractive lines of
business in the health care sector.  We are  confident  that we are becoming the
premier cardiovascular disease management company."

         Statements  contained in this press  release  which are not  historical
facts may be  considered  forward-looking  statements as that term is defined in
the  Private  Securities  Litigation  Reform Act of 1995.  Such  forward-looking
statements  are subject to risks and  uncertainties  which  could  cause  actual
results to differ materially from those projected.  Such risks and uncertainties
include  construction  and development  risks  associated with heart  hospitals;
operating  losses and negative cash flows during the initial  operation of heart
hospitals;  dependence  on  physician  relationships;  dependence  on  long-term
management   contracts;   fluctuations  in  quarterly   operating  results  from
seasonality,  population shifts and other factors; dependence on key management;
as well as other risks detailed in the Company's filings with the Securities and
Exchange Commission.

         MedCath  Incorporated  is a provider of cardiology  and  cardiovascular
services  through the operation of specialized  facilities and the management of
physician  practices.  The Company operates one specialty heart hospital and has
five  additional  heart  hospitals  under  development,  manages  three  medical
practices  comprised of a total of 76  physicians,  manages  fixed-site  cardiac
diagnostic  and  therapeutic  centers,  and owns  and  operates  mobile  cardiac
catheterization laboratories serving networks of hospitals.























                                                                     Page 5 of 6

<PAGE>
<TABLE>
<CAPTION>

                              MEDCATH INCORPORATED
                              Financial Highlights

                                                                       Three Months Ended
                                                                           December 31
                                                                       1996             1995

<S>                                                           <C>                  <C>          
Net revenue                                                   $    22,854,453      $  11,208,633
Operating expenses                                                 19,333,246          8,845,612
                                                                   ----------        -----------

Income from operations                                              3,521,207          2,363,021

Income before income taxes                                          2,923,760          2,043,617
Provision for income taxes                                          1,169,504            817,447

Net income                                                    $     1,754,256       $  1,226,170

Net income per common and common
equivalent share                                              $          0.15       $       0.14

Weighted average number of shares outstanding                      11,684,550          8,989,601


<CAPTION>

                                                                 December 31,        September 30,
                                                                     1996                1996

<S>                                                           <C>                    <C>          
Cash and short-term investments                               $   58,462,519         $  61,693,549

Working capital                                               $   64,554,443         $  65,809,625

Total assets                                                  $  199,368,803         $ 181,920,718

Long-term debt and capital leases,
         excluding current maturities                         $   59,028,243         $  45,895,438

Shareholders' equity                                          $  122,089,346         $ 120,245,093

</TABLE>









                                                                     Page 6 of 6


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission